Entering text into the input field will update the search result below

Agenus’ anti-PD-1 antibody shows activity in both PD-L1 positive and PD-L1 negative tumors

May 20, 2021 8:04 AM ETAgenus Inc. (AGEN) StockAGENBy: Dulan Lokuwithana, SA News Editor22 Comments
  • Agenus (NASDAQ:AGEN) announced new data for balstilimab, an anti-PD-1 antibody, and AGEN2373, a CD137 agonist antibody as contained in abstracts that will be part of two poster presentations scheduled at the American Society for Clinical Oncology (ASCO) Annual Meeting 2021.
  • In

Recommended For You

About AGEN Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
AGEN--
Agenus Inc.